{
    "Trade/Device Name(s)": [
        "EliA anti-TG Immunoassay",
        "EliA anti-TPO Immunoassay",
        "EliA Thyroid Positive Control 250",
        "EliA Thyroid Positive Control 2500/5000"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "K151799",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003414",
        "K993585",
        "K091845",
        "K061165"
    ],
    "Regulatory Class": "Class II (Assays), Class I (Controls)",
    "Product Code(s)": [
        "JZO",
        "JJY"
    ],
    "Summary Letter Date": "February 24, 2016",
    "Summary Letter Received Date": "February 25, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5870",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Thyroid autoantibody immunological test system",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to thyroglobulin (TG)",
        "IgG antibodies to thyroid peroxidase (TPO)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Li-heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 250",
        "Phadia 2500/5000"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative immunofluorescence assay"
    ],
    "Methodologies": [
        "Immunofluorescence",
        "Automated immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for EliA anti-TG and anti-TPO Immunoassays and Thyroid Positive Controls for detection of IgG antibodies to thyroglobulin and thyroid peroxidase as an aid in diagnosing autoimmune thyroiditis and Graves' disease.",
    "Indications for Use Summary": "In vitro quantitative measurement of IgG antibodies to thyroglobulin and thyroid peroxidase in human serum and plasma as an aid in the clinical diagnosis of autoimmune thyroiditis and Graves' disease, with controls intended for monitoring assay performance, used on Phadia 250 or Phadia 2500/5000 platforms.",
    "fda_folder": "Immunology"
}